CPC A61K 31/05 (2013.01) [A61K 9/0034 (2013.01); A61K 9/127 (2013.01); A61K 31/13 (2013.01); A61K 31/137 (2013.01); A61K 31/352 (2013.01); A61K 31/417 (2013.01); A61K 31/4458 (2013.01); A61K 31/472 (2013.01); A61K 31/475 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/53 (2013.01); A61K 31/55 (2013.01); A61K 31/5575 (2013.01); A61K 31/568 (2013.01); A61K 36/88 (2013.01); A61K 38/12 (2013.01); A61P 15/10 (2018.01)] | 28 Claims |
1. A method of treating female sexual dysfunction induced by one or more antidepressants, previously administered to a female subject, the method comprising applying topically a composition consisting of CBD as the sole active ingredient (“CBD-containing composition”), said composition being applied to the mucosal surface of female subject's genital arousal area(s), wherein the composition is applied in an amount and for a period of time prior to a sexual activity such that sexual dysfunction of the subject is ameliorated during the sexual activity.
|